Publicaciones en colaboración con investigadores/as de Hospital Álvaro Cunqueiro (35)

2026

  1. Bilateral pheochromocytoma: differences in clinical and surgical outcomes with unilateral pheochromocytomas

    Endocrine, Vol. 91, Núm. 1

  2. Biological therapies for inflammatory pouch disorders: insights and outcomes from the RESERVO study of GETECCU

    Therapeutic Advances in Gastroenterology, Vol. 19

  3. Determinants of long-acting cabotegravir plus rilpivirine discontinuation in real-world HIV care: insights from the RELATIVITY cohort

    AIDS, Vol. Publish Ahead of Print

  4. Effectiveness and Persistence of Long-Acting Injectable Cabotegravir and Rilpivirine in Migrant Individuals Living With HIV in Spain: Substudy of the RELATIVITY Cohort

    Journal of the International AIDS Society, Vol. 29, Núm. 4

  5. Long-acting cabotegravir and rilpivirine in people with HIV and obesity: Real-world outcomes from the RELATIVITY cohort

    HIV Medicine, Vol. 27, Núm. 5, pp. 690-709

  6. Prevalence of Active HCV Infection in Spain in 2022 Using Multiparameter Evidence Synthesis

    Journal of Viral Hepatitis, Vol. 33, Núm. 4

  7. Trends in Hepatitis C Virus Infection Prevalence Among People With HIV in Spain Over 2 Decades (2002-2023)

    Clinical Infectious Diseases, Vol. 82, Núm. 3, pp. e511-e520

2025

  1. Are children and adolescents living with HIV in Europe and South Africa at higher risk of SARS-CoV-2 and poor COVID-19 outcomes?

    Epidemiology and Infection, Vol. 153

  2. Bicaval TricValve Implantation in Patients With Severe Tricuspid Regurgitation: 1-Year Outcomes From the TricBicaval Registry

    JACC: Cardiovascular Interventions, Vol. 18, Núm. 15, pp. 1913-1924

  3. Guideline-directed medical therapy for heart failure in arrhythmia-induced cardiomyopathy with improved left ventricular ejection fraction

    European Journal of Heart Failure, Vol. 27, Núm. 3, pp. 442-452

  4. Impact of presurgical beta-blockade on surgical outcomes in patients with PPGLs

    Endocrine-related cancer, Vol. 32, Núm. 12

  5. Increased mortality and morbidity risk in people with early HIV care interruption in Spain

    AIDS, Vol. 39, Núm. 9, pp. 1224-1234

  6. Intervención telemática sobre la fragilidad en pacientes tratados con TAVI: diseño del ensayo clínico TELE-FRAIL TAVI

    REC: Interventional Cardiology, Vol. 7, Núm. 4, pp. 223-228

  7. Left ventricular ejection fraction and benefit of tricuspid valve interventions – insights from the international TRIGISTRY

    European Journal of Heart Failure, Vol. 27, Núm. 11, pp. 2634-2643

  8. Parkinson’s disease medication adjustments based on wearable device information compared to other methods: randomized clinical trial

    npj Parkinson's Disease, Vol. 11, Núm. 1

  9. Sex-specific response to cardiac resynchronization therapy: the BIO|WOMEN trial

    International Journal of Cardiology, Vol. 438

2024

  1. A comparison of simplified or conventional antithrombotic regimens after left atrial appendage closure in patients at high bleeding risk: the PLATEBRISK study

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 20, Núm. 16, pp. 1018-1028

  2. Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain

    AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314

  3. Bicaval TricValve Implantation in Patients With Severe Symptomatic Tricuspid Regurgitation: 1-Year Follow-Up Outcomes

    JACC: Cardiovascular Interventions, Vol. 17, Núm. 1, pp. 60-72

  4. Consensus on the approach to hydrosaline overload in acute heart failure. SEMI/SEC/S.E.N. recommendations

    Revista Espanola de Cardiologia, Vol. 77, Núm. 7, pp. 556-565